These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12714144)

  • 1. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound.
    Degertekin M; Regar E; Tanabe K; Lemos P; Lee CH; Smits P; de Feyter P; Bruining N; Sousa E; Abizaid A; Ligthart J; Serruys PW
    Am J Cardiol; 2003 May; 91(9):1046-50. PubMed ID: 12714144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
    Serruys PW; Degertekin M; Tanabe K; Abizaid A; Sousa JE; Colombo A; Guagliumi G; Wijns W; Lindeboom WK; Ligthart J; de Feyter PJ; Morice MC;
    Circulation; 2002 Aug; 106(7):798-803. PubMed ID: 12176950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
    Kaneda H; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ;
    Int J Cardiol; 2010 Jan; 138(2):126-30. PubMed ID: 18804877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
    Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
    J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilation.
    Muñoz JS; Abizaid A; Albertal M; Mintz GS; Graebin R; Feres F; Staico R; Mattos LA; Tanajura LF; Abizaid AS; Sousa A; Sousa JE
    Am J Cardiol; 2004 Jun; 93(12):1522-5. PubMed ID: 15194025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular ultrasound comparison of small coronary lesions between novel guidewire-based sirolimus-eluting stents and conventional sirolimus-eluting stents.
    Kume T; Waseda K; Koo BK; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Yock PG; Azevedo de Oliveira FR; Abizaid A; Fitzgerald PJ; Honda Y
    J Invasive Cardiol; 2012 Oct; 24(10):489-93. PubMed ID: 23043031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
    Sera F; Awata M; Uematsu M; Kotani J; Nanto S; Nagata S
    JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.
    Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Naka KK; Fotiadis DI; Michalis LK
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1181-9. PubMed ID: 21087755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study.
    Hur SH; Ako J; Shimada Y; Tsujino I; Hassan AH; Abizaid A; Shiran A; Lewis BS; Guagliumi G; Cohen SA; Honda Y; Fitzgerald PJ; Sousa JE
    J Invasive Cardiol; 2008 Aug; 20(8):411-6. PubMed ID: 18688066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
    Eshtehardi P; Cook S; Wandel S; Räber L; Wenaweser P; Togni M; Vogel R; Garachemani A; Eberli FR; Lüscher TF; Jüni P; Hess OM; Meier B; Windecker S
    EuroIntervention; 2010 Sep; 6(4):467-74. PubMed ID: 20884434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
    Takebayashi H; Mintz GS; Carlier SG; Kobayashi Y; Fujii K; Yasuda T; Costa RA; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps E; Collins MB; Colombo A; Stone GW; Leon MB; Moses JW
    Circulation; 2004 Nov; 110(22):3430-4. PubMed ID: 15557367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.